
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [NBIX] Neurocrine Biosciences Inc
Data updated 2022-Apr-07 (Thursday)Compare current performance/technical metrics to history for Neurocrine Biosciences Inc. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2022-Apr-07 Thursday
Day Change | -0.05% Mid | Day Volatility | 1.68% Low |
Streak | ↓ 1 day Mid | % Streak | -0.05% Mid |
RSI | 70 Top | CCI | 177.5 Top |
MACD | 0.24 Mid | ATR | 2.76 Low |
ADX | 27.3 Mid | SSO | 81.7 Mid |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | +5.06% Top | 6.84% Mid | +1.09% Mid |
10-day | +4.72% Mid | 9.06% Mid | +3.29% Top |
20-day | +8.34% Mid | 13.23% Mid | +4.86% Top |
50-day | +30.43% Top | 38.17% Top | +11.49% Top |
100-day | +11.92% Mid | 38.95% Mid | +15.46% Top |
200-day | -1.77% Mid | 50.28% Mid | +8.42% Mid |
Choose Metric type
Select Performance timeframe above to analyze
On 2022-Apr-07, Neurocrine Biosciences Inc had:daily change of -0.05% intraday volatility of 1.7% 1 ↓ (down) day streak yielding -0.05% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2022-Apr-07 value annotated for comparison
Related to Neurocrine Biosciences Inc
Information for Neurocrine Biosciences Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jul-03 on Google
SEC Reports : Quarterly reports around 2025-Jul-03 on SEC Edgar
Compare Neurocrine Biosciences Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Neurocrine Biosciences Inc
Industry : Biotechnology industry performance which includes Neurocrine Biosciences Inc